Wolters Kluwer Update on Shares Held in Treasury
Feb 23, 2017 13:31 pm UTC| Business
Wolters Kluwer Update on Shares Held in Treasury February 23, 2017 - Wolters Kluwer announces that, following the release of 1.4 million ordinary shares under the Long-Term Incentive Plan (LTIP) 2014-16, the number...
Meritage Announces Common Stock Cash Dividend; 33.3% Increase Over Same Period Last Year
Feb 23, 2017 13:31 pm UTC| Business
GRAND RAPIDS, Mich., Feb. 23, 2017 -- Meritage Hospitality Group, Inc. (OTCQX:MHGU), one of the nation’s premier restaurant operators, today announced that the Company’s Board of Directors approved a special quarterly...
Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
Feb 23, 2017 13:31 pm UTC| Business
PLAINSBORO, N.J., Feb. 23, 2017 -- Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary,...
Integra LifeSciences Announces Acceptance of Shares Tendered into Offer for Derma Sciences, Inc.
Feb 23, 2017 13:31 pm UTC| Business
PLAINSBORO, N.J., Feb. 23, 2017 -- Integra LifeSciences Holdings Corporation (“Integra”) (NASDAQ:IART), a global leader in medical technology, announced today that its tender offer by its wholly-owned subsidiary,...
Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2016 Financial Results Call for March 9
Feb 23, 2017 13:31 pm UTC| Business
NEW YORK, Feb. 23, 2017 -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that it will host a...
Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2016 Financial Results Call for March 9
Feb 23, 2017 13:31 pm UTC| Business
NEW YORK, Feb. 23, 2017 -- Progenics Pharmaceuticals, Inc., (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that it will host a...
ImmuDyne Appoints Chief Operating Officer/Chief Technology Officer
Feb 23, 2017 13:31 pm UTC| Business
MT. KISCO, N.Y., Feb. 23, 2017 -- ImmuDyne, Inc. (OTCQB:IMMD) (“Immudyne” or the “Company”), a leader in the development and marketing of OTC healthcare products, today announced the appointment of Stefan Galluppi as...